Latest news
Experimental Therapeutics Centre and Debiopharm Group™ to collaborate for the development of an epigenetic innovative oncology target
Presented by the Japanese Cancer Association and Debiopharm Group™ the ‘JCA Mauvernay Award 2013’ goes to Doctors Kitabayashi and Yano
Debiopharm Group™ inaugure la « Debiopharm academy » à l’EPFL avec une première conférence sur la médecine personnalisée
Debiopharm Group™ a le plaisir d’annoncer les étudiants choisis pour les Bourses d’excellence
Debiopharm Investment SA entre dans le capital de la start-up de l’EPFL Smallrivers SA, éditeur du service Paper.li
Debiopharm Group™ and TCG Lifesciences Ltd. enter into an exclusive research agreement to develop a novel class of antibiotics, a…
Go To Market Consulting Inc. and Debiopharm Group™ collaborate to identify early stage in-licensing opportunities on the US West Coast
KeyLemon secures Series A Investment co-led by Debiopharm Investment and Swisscom ventures
Stay informed
Don't miss any latest news and announcements on Debiopharm Investment, subscribe to our newsletter.